Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 3
2001 2
2002 1
2004 2
2005 2
2006 2
2007 3
2008 3
2009 4
2010 5
2011 2
2012 8
2013 5
2014 7
2015 11
2016 14
2017 6
2018 10
2019 8
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 33139263

100 results
Results by year
Filters applied: . Clear all
Page 1
The effect of disease-modifying antirheumatic drugs on vaccine immunogenicity in adults.
Day AL, Winthrop KL, Curtis JR. Day AL, et al. Cleve Clin J Med. 2020 Nov 2;87(11):695-703. doi: 10.3949/ccjm.87a.20056. Cleve Clin J Med. 2020. PMID: 33139263 Free article. Review.
Vaccines and Disease-Modifying Antirheumatic Drugs: Practical Implications for the Rheumatologist.
Friedman MA, Winthrop KL. Friedman MA, et al. Rheum Dis Clin North Am. 2017 Feb;43(1):1-13. doi: 10.1016/j.rdc.2016.09.003. Epub 2016 Oct 22. Rheum Dis Clin North Am. 2017. PMID: 27890167 Review.
Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA, Griffith J, Ganguli A, Li N, Douglas K, Wu EQ. Betts KA, et al. Clin Ther. 2016 May;38(5):1205-16. doi: 10.1016/j.clinthera.2016.03.013. Epub 2016 Apr 2. Clin Ther. 2016. PMID: 27045991
Health Care Effect of Disease-Modifying Antirheumatic Drug Use on Patients with Rheumatoid Arthritis.
Boytsov NN, Bhattacharya R, Saverno K, Dixon L, Abbott PL, Zhang X, Gaich CL, Nair R. Boytsov NN, et al. J Manag Care Spec Pharm. 2019 Aug;25(8):879-887. doi: 10.18553/jmcp.2019.25.8.879. J Manag Care Spec Pharm. 2019. PMID: 31347977
An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR. van Roon EN, et al. Clin Ther. 2009 Aug;31(8):1737-46. doi: 10.1016/j.clinthera.2009.08.009. Clin Ther. 2009. PMID: 19808132 Review.
Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G, Barner JC, Rascati K, Richards K. Kim G, et al. Clin Ther. 2016 Mar;38(3):646-54. doi: 10.1016/j.clinthera.2016.01.022. Epub 2016 Feb 18. Clin Ther. 2016. PMID: 26899313
Factors associated with the initiation of biologic disease-modifying antirheumatic drugs in Texas Medicaid patients with rheumatoid arthritis.
Kim G, Barner JC, Rascati K, Richards K. Kim G, et al. J Manag Care Spec Pharm. 2015 May;21(5):401-7. doi: 10.18553/jmcp.2015.21.5.401. J Manag Care Spec Pharm. 2015. PMID: 25943001
A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S, Bechman K, Rutherford AI, Goldblatt D, Galloway JB. Subesinghe S, et al. J Rheumatol. 2018 Jun;45(6):733-744. doi: 10.3899/jrheum.170710. Epub 2018 Mar 15. J Rheumatol. 2018. PMID: 29545454
Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept.
Alten R, Bingham CO 3rd, Cohen SB, Curtis JR, Kelly S, Wong D, Genovese MC. Alten R, et al. BMC Musculoskelet Disord. 2016 May 26;17:231. doi: 10.1186/s12891-016-1082-z. BMC Musculoskelet Disord. 2016. PMID: 27229685 Free PMC article. Clinical Trial.
Management of vaccination in rheumatic disease.
Wong PKK, Hanrahan P. Wong PKK, et al. Best Pract Res Clin Rheumatol. 2018 Dec;32(6):720-734. doi: 10.1016/j.berh.2019.03.006. Epub 2019 Apr 17. Best Pract Res Clin Rheumatol. 2018. PMID: 31427051 Review.
100 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback